Elevai Labs Inc (ELAB) News

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

NEWPORT BEACH, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (formerly known as Elevai Labs...

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

NEWPORT BEACH, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (formerly known as Elevai Labs...

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation

EL-22, a first-in-class myostatin asset, is being developed as a potential combination therapy with GLP-1...

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Elevai Skincare Expands into Hair Care with Cutting-Edge Scalp and Hair Health System.Root Renewal System...

Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division

Skincare Division Achieves New Sales Milestone, Enters Holiday Season with Strong MomentumStrategic...

Form 8-K - Current report

Form 8-K - Current report

Form DEFR14C - Revised information statement materials, definitive

Form DEFR14C - Revised information statement materials, definitive

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the...

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the...

Form 8-K - Current report

Form DEF 14C - Other definitive information statements

Form DEF 14C - Other definitive information statements